Endometrial cancer MRI: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(26 intermediate revisions by 3 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Pelvic MRI may be diagnostic of endometrial cancer.
The MRI is not needed for the diagnosis of endometrial cancer. However, an MRI may be helpful in staging of the disease.<ref name=":0">{{Cite web | title =endometrial cancer MRI  | url =http://radiopaedia.org/articles/endometrial-carcinoma}}</ref>


==Pelvic MRI==
==Pelvic MRI==
A dedicated pelvic MRI protocol is recommended for optimal assessment.<ref>{{Cite web | title =endometrial cancer MRI  | url =http://radiopaedia.org/articles/endometrial-carcinoma}}</ref>
The MRI is not needed for the diagnosis of endometrial cancer. However, an MRI may be helpful in staging of the disease.<ref name=":0" />
MRI is considered superior to CT for local staging. Contrast enhanced MRI imaging improves accuracy in detecting myometrial invasion.
* T1: hypo- to isointense to normal [[endometrium]]
* T1 C+(Gd): carcinomatous tissue will enhance less than normal endometrium
* T2: hyperintense or heterogeneous relative to normal endometrium


{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center"
| valign="top" |
|+
'''MR Imaging findings according to FIGO stage'''
'''MR Imaging findings according to FIGO stage'''
:* stage 1: [[tumour]] confined to [[uterus]]
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Stage of endometrial cancer}}
::* stage 1a: tumour confined to the uterine endometrium
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|MRI findings}}
:::* normal or widened endometrium
|-
:::* normal low T2 signal junctional zone
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:::* complete subendometrial enhancement on T1 contrast imaging
Stage 1: tumor confined to uterus
::* stage 1b: invasion of less than half of the myometrium
| style="padding: 5px 5px; background: #F5F5F5;" |
:::* disruption or irregularity of the low T2 signal junctional zone
:1a.
:::* disruption of subendometrial early enhancement
::* stage 1c: invasion of outer half of myometrium
:::* disruption or irregularity of the low T2 signal junctional zone
:::* disruption of subendometrial early enhancement
:::* preservation of band of outer [[myometrium]]
:* stage 2: tumour extends to [[cervix]]
::* stage 2a
:::* widening of internal os and endocervical canal by high/isointense T2W signal tumour mass.
:::* intact low T2W signal of normal cervical stroma
::* stage 2b
:::* widening of internal os and endocervical canal by high/isointense T2W signal tumour mass
:::* disruption of low T2 signal cervical stroma
:* stage 3: tumour extension beyond the [[uterus]]
::* stage 3a
:::* irregularity to the uterine contour
:::* disruption of low T2 signal uterine serosa
::* stage 3b
:::* thickening of vaginal wall
:::* high T2 signal tumour infiltrating low signal vaginal wall
::* stage 3c
:::* pelvic/para aortic lymph node involvement
:::* short axis >/= 8 mm in pelvic nodes
:* stage 4: bladder/rectal or distant metastasis
::* stage 4a
:::* disruption of low T2 signal [[bladder]] or rectal wall
:::* intraluminal bladder mass


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
:* Disruption or irregularity of the low T2 signal junctional zone
|+
:* Disruption of subendometrial early enhancement
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Stage}}
:1b.
! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|MRI Findings}}
:* Disruption or irregularity of the low T2 signal junctional zone
|-
:* Disruption of subendometrial early enhancement
| style="padding: 5px 5px; background: #DCDCDC;" | '''Stage I'''
:* Preservation of band of outer myometrium
| style="padding: 5px 5px; background: #F5F5F5;" | Tumor confined to the corpus uteri
|-
|  rowspan=4 style="padding: 5px 5px; background: #DCDCDC;" | '''IA'''
| style="padding: 5px 5px; background: #F5F5F5;" | No or less than half myometrial invasion
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
|-
| style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
|-
|  rowspan=3 style="padding: 5px 5px; background: #DCDCDC;" | '''IB'''
| style="padding: 5px 5px; background: #F5F5F5;" | Invasion equal to or more than half of the [[myometrium]]
|-
| style="padding: 5px 5px; background: #F5F5F5;" |  disruption or irregularity of the low T2 signal junctional zone
|-
| style="padding: 5px 5px; background: #F5F5F5;" |  disruption of subendometrial early enhancement
|-
|  rowspan=3 style="padding: 5px 5px; background: #DCDCDC;" |'''Stage II'''
| style="padding: 5px 5px; background: #F5F5F5;" | Tumor invades cervical stroma but does not extend beyond the [[uterus]]
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
|-
| style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Stage III'''
| style="padding: 5px 5px; background: #F5F5F5;" | Local and/or regional spread of the tumor
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
|-
| style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
|-
|style="padding: 5px 5px; background: #DCDCDC;" |'''IIIA'''
| style="padding: 5px 5px; background: #F5F5F5;" | Tumor invades the serosa of the corpus uteri and/or adnexae
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
|-
| style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
|-
| style="padding: 5px 5px; background: #DCDCDC;" |'''IIIB'''
| style="padding: 5px 5px; background: #F5F5F5;" | Vaginal involvement and/or parametrial involvement
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
Stage 2: tumor extends to cervix
| style="padding: 5px 5px; background: #F5F5F5;" |
:* Widening of internal os and endocervical canal by high/isointense T2W signal tumor mass.
:* Intact low T2W signal of normal cervical stroma
:* Disruption of low T2 signal cervical stroma
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
|-
Stage 3: tumor extension beyond the uterus
| rowspan=3 style="padding: 5px 5px; background: #DCDCDC;" | '''III C'''
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" | Metastases to pelvic and/or para-aortic lymph nodes
:3a
|-
:* Irregularity to the uterine contour
| style="padding: 5px 5px; background: #F5F5F5;" | (i) Positive pelvic nodes
:* Disruption of low T2 signal uterine serosa
|-
:3b
| style="padding: 5px 5px; background: #F5F5F5;" | (ii) Positive para-aortic nodes with or without positive pelvic [[lymph nodes]]
:* Thickening of vaginal wall
|-
:* High T2 signal tumor infiltrating low signal vaginal wall
| style="padding: 5px 5px; background: #DCDCDC;" | '''Stage IV'''
:3c
| style="padding: 5px 5px; background: #F5F5F5;" | Tumor invades bladder and/or bowel mucosa, and/or distant metastases
:* Pelvic/para aortic lymph node involvement
|-
:* Short axis ≥ 8 mm in pelvic nodes
| style="padding: 5px 5px; background: #DCDCDC;" | '''IVA'''
| style="padding: 5px 5px; background: #F5F5F5;" | Tumor invasion of [[bladder]] and/or bowel mucosa
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
|-
| style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''IVB'''
| style="padding: 5px 5px; background: #F5F5F5;" | Distant metastasis, including intra-abdominal [[metastases]] and/or inguinal nodes
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
|-
| style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
|-
| style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" |
Stage 4: bladder/rectal or distant metastasis
| style="padding: 5px 5px; background: #F5F5F5;" |
:4a
:* Disruption of low T2 signal [[bladder]] or rectal wall
:* Intraluminal bladder mass
|}
|}


Line 149: Line 67:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gynecology]]
[[Category:Surgery]]

Latest revision as of 14:42, 29 November 2018

Endometrial cancer Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Endometrial cancer from other Diseases

Epidemiology and Demographics

Risk factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Endometrial cancer MRI On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Endometrial cancer MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Endometrial cancer MRI

CDC on Endometrial cancer MRI

Endometrial cancer MRI in the news

Blogs on Endometrial cancer MRI

Directions to Hospitals Treating Endometrial cancer

Risk calculators and risk factors for Endometrial cancer MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]

Overview

The MRI is not needed for the diagnosis of endometrial cancer. However, an MRI may be helpful in staging of the disease.[1]

Pelvic MRI

The MRI is not needed for the diagnosis of endometrial cancer. However, an MRI may be helpful in staging of the disease.[1]

MR Imaging findings according to FIGO stage
Stage of endometrial cancer MRI findings

Stage 1: tumor confined to uterus

1a.
  • Disruption or irregularity of the low T2 signal junctional zone
  • Disruption of subendometrial early enhancement
1b.
  • Disruption or irregularity of the low T2 signal junctional zone
  • Disruption of subendometrial early enhancement
  • Preservation of band of outer myometrium

Stage 2: tumor extends to cervix

  • Widening of internal os and endocervical canal by high/isointense T2W signal tumor mass.
  • Intact low T2W signal of normal cervical stroma
  • Disruption of low T2 signal cervical stroma

Stage 3: tumor extension beyond the uterus

3a
  • Irregularity to the uterine contour
  • Disruption of low T2 signal uterine serosa
3b
  • Thickening of vaginal wall
  • High T2 signal tumor infiltrating low signal vaginal wall
3c
  • Pelvic/para aortic lymph node involvement
  • Short axis ≥ 8 mm in pelvic nodes

Stage 4: bladder/rectal or distant metastasis

4a
  • Disruption of low T2 signal bladder or rectal wall
  • Intraluminal bladder mass

References

  1. ↑ 1.0 1.1 "endometrial cancer MRI".


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Endometrial_cancer_MRI&oldid=1505363"